Health Policy Watch | The Health Financing Crisis Demands Innovation: Lessons From Pooled Sputum Testing for TB
10 November 2026
Health Policy Watch analysis
An estimated one in four people with TB globally are still undiagnosed and untreated. WHO recommends that everyone with signs and symptoms of TB receive a rapid molecular test as their initial diagnostic, yet only 54% currently do, largely because these tests remain costly for health systems and therefore out of reach for many.
Pooled testing addresses this gap: by testing multiple samples together, it stretches limited resources further, allowing more people to access testing using the same platforms that can detect TB and drug resistance within hours rather than weeks.
This challenge is becoming more pressing as global health enters a new era of constrained financing. The decline in donor funding underscores the need for increased domestic funding and greater national ownership of health programs. But this shift will not happen overnight. In the meantime, across countries, fewer people are being reached with essential services, and progress against diseases like TB is at risk of being reversed. Millions continue to face stark barriers to access the diagnosis, treatment and care they need.
As funding tightens, it is essential for governments, funders and global health partners to continue investing in research, development and innovation, because diseases do not slow down when funding does: they continue to evolve, spread, and adapt.
Meeting the challenge in today’s constrained financial environment will require a broader view of innovation, one that goes beyond developing new technologies to include smarter ways of delivering existing technologies.
Read the full analysis here.
Source: Health Policy Watch
